TB is the world’s deadliest infectious disease
Every $1 invested in TB yields a $42 return in economic benefit for TB affected countries, with significant positive impact on national GDPs.
STBP is changing how we do BUSINESS in TB and global health
Current approaches and systems cannot efficiently and effectively achieve our targets and goals nor address future TB and global health challenges
What are Rtc’s Superpowers?
We thrive on taking bold and smart risks to challenge the status quo
